Another study demonstrated that low-dose IL-2 can induce a sharp decrease in the levels of thyroglobulin antibody (TG-Ab) and thyroid peroxidase antibody (TPO-Ab), thereby playing a certain role in the treatment of autoimmune thyroid diseases (66), which is consistent with the conclusions of our research. The gene discussed is IL2; the disease is autoimmune thyroid disease.